Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials
Federica Fogacci, Giuseppe Danilo Norata, Peter P. Tóth, et al.
Current Atherosclerosis Reports (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Lipid Lowering Drugs: Present Status and Future Developments
Massimiliano Ruscica, Nicola Ferri, Raúl D. Santos, et al.
Current Atherosclerosis Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 61
Lipid Lowering Therapy: An Era Beyond Statins
Toufik Abdul‐Rahman, Syed Muhammad Awais Bukhari, Emiliano Cantu‐Herrera, et al.
Current Problems in Cardiology (2022) Vol. 47, Iss. 12, pp. 101342-101342
Closed Access | Times Cited: 55
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
Clarice Gareri, Alberto Polimeni, Salvatore Giordano, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3884-3884
Open Access | Times Cited: 43
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Mingming Chen, Xuewei Huang, Chengsheng Xu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
Lipids dysregulation in diseases: core concepts, targets and treatment strategies
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials
Ilenia Calcaterra, Roberta Lupoli, Alessandro Di Minno, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 11
Open Access | Times Cited: 30
A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD
Rai Ajit K. Srivastava
Cells (2023) Vol. 12, Iss. 12, pp. 1648-1648
Open Access | Times Cited: 17
Genetics of hypertriglyceridemia and atherosclerosis
Praneet K. Gill, Jacqueline S. Dron, Robert A. Hegele
Current Opinion in Cardiology (2021) Vol. 36, Iss. 3, pp. 264-271
Closed Access | Times Cited: 36
Severe insulin resistance syndromes
Angeliki M. Angelidi, Andreas Filippaios, Christos S. Mantzoros
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 35
Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia
Genovefa Kolovou, Vana Kolovou, Niki Katsiki
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 982-982
Open Access | Times Cited: 23
ApoCIII: A multifaceted protein in cardiometabolic disease
Laura D’Erasmo, Alessia Di Costanzo, Antonio Gallo, et al.
Metabolism (2020) Vol. 113, pp. 154395-154395
Open Access | Times Cited: 35
Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes
Annemieke Naber, Daniel Demus, Roderick C. Slieker, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5365-5365
Open Access | Times Cited: 4
Volanesorsen for treatment of familial chylomicronemia syndrome
Julieta Lazarte, Robert A. Hegele
Expert Review of Cardiovascular Therapy (2021) Vol. 19, Iss. 8, pp. 685-693
Closed Access | Times Cited: 24
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
Chih‐Kuo Lee, Che‐Wei Liao, Shih‐Wei Meng, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 985-985
Open Access | Times Cited: 24
Real life evidence of volanesorsen for Familial Chylomicronemia Syndrome in Colombia.
Alejandro Román‐González, Alejandro Castellanos, Diego Felipe Sánchez Perdomo, et al.
Journal of clinical lipidology (2025)
Open Access
Pharmaceutical Perspectives on Oligonucleotide Therapeutics and Delivery Systems
Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, et al.
Pharmacological Reviews (2025), pp. 100065-100065
Closed Access
Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1278-1278
Open Access | Times Cited: 15
Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic
José Rioja, María José Ariza, Natalia García‐Casares, et al.
European Journal of Clinical Investigation (2020) Vol. 50, Iss. 12
Closed Access | Times Cited: 22
The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
Helen Huang, Sarah M. Badar, Mohammad Said, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
Pedro Valdivielso, Inmaculada Coca Prieto
Med (2024) Vol. 5, Iss. 6, pp. 493-494
Closed Access | Times Cited: 2
Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia
Naif Saad ALGhasab, Federica Fogacci, Ashot Avagimyan, et al.
Expert Opinion on Pharmacotherapy (2024)
Closed Access | Times Cited: 2
Disorders of Lipid Metabolism
Rushika Conroy, Stewart A. Mackie, Charlotte M. Boney
Pediatric Endocrinology (2024), pp. 859-887
Closed Access | Times Cited: 2
Present and Future of Dyslipidaemia Treatment—A Review
Iveta Merćep, Andro Vujević, Dominik Strikić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5839-5839
Open Access | Times Cited: 6
Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica
Abel A. Pavía-López, Marco A. Alcocer‐Gamba, Edith Ruiz-Gastélum, et al.
Archivos de cardiología de México (2022) Vol. 92, Iss. 91
Open Access | Times Cited: 7
Two successful pregnancies ‐in patients taking Volanesorsen for familial chylomicronemia syndrome
Subadra Wanninayake, Antonio Ochoa‐Ferraro, Karishma Patel, et al.
JIMD Reports (2024) Vol. 65, Iss. 4, pp. 249-254
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top